Delfi launches its blood test to screen for lung cancer – and reveals challenges for liquid biopsies
Taking aim at a major killer, the well-funded startup Delfi Diagnostics launches a blood test to screen for lung cancer.
Taking aim at a major killer, the well-funded startup Delfi Diagnostics launches a blood test to screen for lung cancer.
Federal public health officials are turning to wastewater surveillance to help fill in the gaps in efforts to track H5N1 bird flu outbreaks in dairy…
Late-stage results of Cytokinetics’ drug for a rare heart disease suggest it can compete with a similar treatment sold by Bristol Myers Squibb, and can…
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
Late-stage results of Cytokinetics’ drug for a rare heart disease suggest it can compete with a similar treatment sold by Bristol Myers Squibb, and can…
Tome laid out for the first time how it plans to use CRISPR: —Initially to treat a rare disease called phenylketonuria —To design a natural…
The FDA “needs to show some leadership … but instead, they have been flip-flopping for years,” said Tahir Amin of the Initiative for Medicines, Access…
Advocates and biotech executives hope that AI can help speed a wave of custom medicines. A new study suggests that outcome may still be years…
Cliff Douglas is the new president and CEO of a foundation his former colleagues in the anti-smoking movement say is inextricably linked to his former…
The FDA “needs to show some leadership … but instead, they have been flip-flopping for years,” said Tahir Amin of the Initiative for Medicines, Access…
Cliff Douglas is the new president and CEO of a foundation his former colleagues in the anti-smoking movement say is inextricably linked to his former…